| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.18B | 22.01B | 21.22B | 20.72B | 18.89B | 18.28B |
| Gross Profit | 4.26B | 4.37B | 4.18B | 4.08B | 3.78B | 3.65B |
| EBITDA | 2.06B | 2.08B | 1.99B | 2.00B | 1.79B | 1.74B |
| Net Income | 983.70M | 1.02B | 928.80M | 1.01B | 846.10M | 823.00M |
Balance Sheet | ||||||
| Total Assets | 14.85B | 14.54B | 14.14B | 13.87B | 13.40B | 13.59B |
| Cash, Cash Equivalents and Short-Term Investments | 17.90M | 67.30M | 29.40M | 29.50M | 13.40M | 445.80M |
| Total Debt | 4.87B | 4.60B | 4.31B | 4.32B | 4.12B | 4.56B |
| Total Liabilities | 7.81B | 7.49B | 7.10B | 7.05B | 6.78B | 7.18B |
| Stockholders Equity | 7.02B | 7.03B | 7.02B | 6.80B | 6.60B | 6.40B |
Cash Flow | ||||||
| Free Cash Flow | 1.14B | 1.16B | 1.06B | 867.60M | 847.80M | 969.90M |
| Operating Cash Flow | 1.56B | 1.61B | 1.56B | 1.46B | 1.37B | 1.49B |
| Investing Cash Flow | -404.50M | -424.00M | -471.50M | -586.90M | -492.70M | -487.30M |
| Financing Cash Flow | -1.14B | -1.15B | -1.09B | -861.80M | -1.31B | -998.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | C$2.64B | 13.57 | 18.69% | 3.27% | 2.08% | 9.31% | |
68 Neutral | C$11.02B | 17.29 | 12.66% | 1.78% | 2.58% | 7.85% | |
66 Neutral | C$20.38B | 23.42 | 14.48% | 1.50% | 3.71% | 12.40% | |
65 Neutral | C$37.60B | 5.57 | 26.36% | 1.23% | 4.15% | 149.50% | |
64 Neutral | C$73.21B | 27.64 | 21.51% | 1.52% | 4.21% | 14.03% | |
64 Neutral | C$54.54B | 38.95 | 102.01% | 0.20% | 14.02% | 20.11% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
Metro Inc., a major food and pharmacy retailer in Québec and Ontario with more than 1,000 grocery stores and 640 pharmacies under multiple banners, continues to expand its integrated retail, distribution and e-commerce operations. The company generates over $22 billion in annual sales and employs more than 97,000 people across its network in central Canada.
Metro has priced a C$350 million private placement of 3.469% Series M senior unsecured notes maturing in 2031, with proceeds earmarked to repay borrowings under its revolving credit facility and for general corporate purposes. The BBB-rated notes, offered in Canada to institutional investors and ranking pari passu with Metro’s other unsecured debt, are expected to close on February 25, 2026, underscoring the company’s continued access to investment-grade funding and balance sheet management flexibility.
The most recent analyst rating on (TSE:MRU) stock is a Hold with a C$97.00 price target. To see the full list of analyst forecasts on Metro Inc. stock, see the TSE:MRU Stock Forecast page.
Metro Inc. announced that all 11 management-nominated directors were elected to its board at the company’s January 27, 2026 annual general meeting of shareholders, each securing strong majority support in the votes cast. The reaffirmation of the full slate of directors underscores shareholder confidence in the company’s current leadership and strategic direction as it continues to consolidate its position as a major food and pharmacy player in Québec and Ontario, with implications for continuity in governance and stability for investors, employees and other stakeholders.
The most recent analyst rating on (TSE:MRU) stock is a Buy with a C$111.00 price target. To see the full list of analyst forecasts on Metro Inc. stock, see the TSE:MRU Stock Forecast page.
Metro Inc. reported first-quarter fiscal 2026 sales of $5.29 billion, up 3.3% year over year, driven by food same-store sales growth of 1.6% (1.9% adjusted for the Christmas shift), a 25.8% surge in online food sales, and pharmacy same-store sales up 3.9%. Net earnings fell 12.8% to $226.3 million, largely due to $21.6 million in direct costs linked to the temporary shutdown of its frozen food distribution centre in Toronto, but adjusted net earnings rose 1.3% to $248.7 million and adjusted EPS increased 5.5% to $1.16, indicating underlying earnings resilience. Operating income before depreciation and amortization was essentially flat at $482.6 million, with gross margin steady at 19.7% and operating expenses slightly higher as a share of sales because of the distribution centre disruption; excluding these exceptional costs, expense ratios would have improved. The company highlighted market share gains, strong performance of new discount stores and robust online growth despite persistent food inflation and operational challenges, and it raised its quarterly dividend by 10.1%, signaling confidence in its long-term growth strategy and financial strength.
The most recent analyst rating on (TSE:MRU) stock is a Buy with a C$115.00 price target. To see the full list of analyst forecasts on Metro Inc. stock, see the TSE:MRU Stock Forecast page.
METRO Inc. announced it will publish its fiscal 2026 first-quarter results on January 27, 2026, followed by a conference call for investors and financial analysts hosted by President and CEO Eric R. La Flèche and Executive Vice President and CFO Nicolas Amyot. The call, which will include a question period for the financial community and listen-only access for journalists and the public, underscores the company’s continued emphasis on transparent communication with capital markets and stakeholders ahead of a key financial update for one of Canada’s largest food and pharmacy retailers.
The most recent analyst rating on (TSE:MRU) stock is a Buy with a C$113.00 price target. To see the full list of analyst forecasts on Metro Inc. stock, see the TSE:MRU Stock Forecast page.
METRO Inc. announced that it will release its fiscal 2026 first-quarter results on January 27, 2026, followed by a conference call led by President and CEO Eric R. La Flèche and Executive Vice President and CFO Nicolas Amyot for investors and financial analysts, with a subsequent question period. The call, which will also be accessible in listen-only mode to journalists and the public and available as a replay until late February, underscores the company’s ongoing engagement with the financial community and offers stakeholders timely insight into its early 2026 performance in the competitive food and pharmacy retail market in Eastern Canada.
The most recent analyst rating on (TSE:MRU) stock is a Buy with a C$113.00 price target. To see the full list of analyst forecasts on Metro Inc. stock, see the TSE:MRU Stock Forecast page.